FAECAL MICROBIOTA SIGNATURE FOR PANCREATIC CANCER

Patent number:

WO2023/052486 (A1)

Comunidad de Madrid.svg
No items found.

The inventors have found a method for early diagnosing pancreatic cancer based on a faecal microbiota signature with high specificity for pancreatic cancer. The method of the invention is a sensitive, specific and non-invasive method for an early detection of pancreatic cancer, in particular Pancreatic Ductal Adenocarcinoma (PDAC) that could therefore improve survival outcomes. The present invention refers to a method for diagnosing pancreatic cancer in a subject comprising determining the abundance of several Microbiome species in a faecal sample from said subject, as well as to a kit and its use for the diagnosis of pancreatic cancer.

Countries:
Spain
Regions:
Community of Madrid
Centers:
SPANISH NATIONAL CANCER RESEARCH CENTRE
Other entities:
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

High sensitivity in T1-T2 tumours >> Non-invasive test requiring stool >> Cheaper test: €200, aprox. >> High specificity >> Universal application

Comments

Other related patents

Health
Other

PORTABLE BLOOD PRESSURE MEASURING DEVICE AND ELECTROCARDIOGRAM (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries
Spain
Know more
Health

COLORIMERIC METHOD FOR DETECTION OF AMPLIFIED GENETIC MATERIAL AND USES THEREOF

Countries
Portugal
Know more
Health

New therapeutic target for the treatment of myotonic dystrophy

Countries
Spain
Know more
Get back to patents directory